Furthermore, PUMA downregulation has been linked to venetoclax resistance in lymphoma cell lines and chronic lymphocytic leukemia primary cells, where its silencing is mediated by promoter methylation36. This evidence concerns the gene BBC3 and B-cell chronic lymphocytic leukemia.